McMillion Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$3.11K Buy
+14
New +$3.25K ﹤0.01% 173
2022
Q4
Sell
-14
Closed -$3K 81
2022
Q3
$3K Hold
14
﹤0.01% 183
2022
Q2
$3K Buy
+14
New +$3.43K ﹤0.01% 195
2021
Q1
Sell
-81
Closed -$19K 92
2020
Q4
$19K Buy
+81
New +$18.7K 0.01% 174
2020
Q2
Sell
-120
Closed -$24K 78
2020
Q1
$24K Buy
120
+59
+97% +$12.9K 0.02% 125
2019
Q4
$15K Hold
61
0.01% 168
2019
Q3
$12K Hold
61
0.01% 177
2019
Q2
$11K Buy
+61
New +$10.9K 0.01% 186

Other funds holding AMGN

McMillion Capital Management's AMGN Position: Q2 2023 in Review

McMillion Capital Management opened a new position in Amgen (AMGN) in Q2 2023: 14 shares worth $3.11K. The stake represents ﹤0.01% of the portfolio and ranks #173 among its holdings. This is a return to the name: McMillion Capital Management previously reported a position in AMGN as recently as Q3 2022.

McMillion Capital Management first reported a position in AMGN in Q2 2019 and has held it in 8 quarters since. The position peaked at $24K in Q1 2020. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • McMillion Capital Management held 14 shares of Amgen worth $3.11K as of Q2 2023.
  • Amgen was a new McMillion Capital Management position in Q2 2023.
  • Amgen made up ﹤0.01% of McMillion Capital Management's portfolio in Q2 2023, its #173 holding.
  • McMillion Capital Management first reported a position in Amgen in Q2 2019 and has held it in 8 quarters since.
  • McMillion Capital Management's Amgen position peaked at $24K in Q1 2020.
  • 2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on McMillion Capital Management's 13F filing for Q2 2023, filed 8 Aug 2023.